Biochanin A Sensitizes Glioblastoma to Temozolomide by Inhibiting Autophagy
- 4 January 2022
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 59 (2) , 1262-1272
Abstract
Resistance to temozolomide (TMZ) chemotherapy is the main reason for treatment failure in patients with glioblastoma (GBM). In the present study, we investigated biochanin A (BCA) a potent sensitizer of TMZ in GBM. We observed that BCA significantly enhanced cell sensitivity to TMZ in vitro and in vivo. Mechanistically, the specific chemosensitizing effect of BCA is mediated by autophagy inhibition. Moreover, by performing a molecular docking analysis, we demonstrated that BCA interacts with AMPK residues and impairs autophagy by regulating the AMPK/ULK1 pathway. These results suggest that BCA is a potential therapeutic agent that sensitizes GBM to TMZ and provide new insight into its therapeutic potential in chemoresistant GBM.Keywords
Funding Information
- National Natural Science Foundation of China (81960541, 82060455)
- Natural Science Foundation of Gansu Province (18JR3RA309 /18JR3RA365)
- Gansu Science and Technology Department (145RTSA012, 17JR5RA307)
- Lanzhou Science and Technology Bureau (2018-1-109)
This publication has 30 references indexed in Scilit:
- The impact of dietary isoflavonoids on malignant brain tumorsCancer Medicine, 2014
- A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiformeAutophagy, 2014
- Structural basis of AMPK regulation by small molecule activatorsNature Communications, 2013
- Multimechanistic Antifibrotic Effect of Biochanin A in Rats: Implications of Proinflammatory and Profibrogenic MediatorsPLOS ONE, 2013
- Survival and Death Strategies in Glioma Cells: Autophagy, Senescence and Apoptosis Triggered by a Single Type of Temozolomide-Induced DNA DamagePLOS ONE, 2013
- The Double-Edged Sword of Autophagy Modulation in CancerClinical Cancer Research, 2009
- Blocked Autophagy Sensitizes Resistant Carcinoma Cells to Radiation TherapyCancer Research, 2008
- Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patientsJournal of Neuro-Oncology, 2008
- Clinical Trial Substantiates the Predictive Value of O-6-Methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastoma Patients Treated with TemozolomideClinical Cancer Research, 2004
- Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts*The Prostate, 2002